Table 1.
Pertinent Characteristics of INVEST Patients at Baseline
| Variable | N = 22576 |
|---|---|
| Demographic |
|
| Age, mean (SD), years |
66.1 (9.8) |
| Women |
11770 (52.1) |
| Race/Ethnicity |
|
| White |
10925 (48.4) |
| Black |
3029 (13.4) |
| Hispanic |
8045 (35.6) |
| Other/multiracial |
577 (2.6) |
| Verapamil SR Strategy |
11267 (49.9) |
| Atenolol Strategy |
11309 (50.1) |
| History of |
|
| Myocardial infarction |
7218 (32.0) |
| Stroke/transient ischemic attack |
1629 (7.2) |
| Congestive Heart Failure (class I-III) |
1256 (5.6) |
| Diabetes† |
6400 (28.4) |
| Renal impairment‡ |
424 (1.9) |
| Peripheral vascular disease |
2699 (12.0) |
| CABG or PCI |
6166 (27.3) |
| Smoking (ever) |
10454 (46.3) |
| Blood Pressure Systolic Blood Pressure, mean (SD) |
149.5 (19.7) |
| Diastolic Blood Pressure, mean (SD) |
86.3 (12.0) |
| Heart Rate, mean (SD), beats/min | 75.5 (9.5) |
Abbreviations: SD, Standard deviation; CABG, Coronary artery bypass graft; PCI, percutaneous coronary interventions.
Unless indicated otherwise, values express numbers (percentage).
†History of or currently taking antidiabetic medications.
‡History of or currently have elevated serum creatinine level but less than 4 mg/dl (354 μmol/L).